Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stuart, G. R.
Right arrow Articles by Glickman, B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stuart, G. R.
Right arrow Articles by Glickman, B. W.
[Cancer Research 60, 266-268, January 15, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Prostate Mutations in Rats Induced by the Suspected Human Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine

Gregory R. Stuart, James Holcroft, Johan G. de Boer and Barry W. Glickman1

Centre for Environmental Health and Department of Biology, University of Victoria, Victoria, British Columbia, V8W 3N5 Canada

Male lacI transgenic rats were fed a diet containing 200 ppm of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), a heterocyclic amine present in cooked meats. PhIP was found to be a powerful prostate mutagen. After 61 days of treatment, the lacI mutant frequency was 71 x 10-5, >20-fold higher than the spontaneous mutant frequency of 3.2 x 10-5. The predominant PhIP-induced mutations were G:C->T:A transversions and deletions of G:C bp. The results directly link PhIP-induced mutations with the earlier observation of PhIP-induced prostate cancer in rats and suggest that exposure to dietary PhIP could be a risk factor in the incidence of human prostate cancer.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Koutros, A. J. Cross, D. P. Sandler, J. A. Hoppin, X. Ma, T. Zheng, M. C.R. Alavanja, and R. Sinha
Meat and Meat Mutagens and Risk of Prostate Cancer in the Agricultural Health Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 80 - 87.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Nakai, W. G. Nelson, and A. M. De Marzo
The Dietary Charred Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Acts as Both a Tumor Initiator and Promoter in the Rat Ventral Prostate
Cancer Res., February 1, 2007; 67(3): 1378 - 1384.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Cross, U. Peters, V. A. Kirsh, G. L. Andriole, D. Reding, R. B. Hayes, and R. Sinha
A Prospective Study of Meat and Meat Mutagens and Prostate Cancer Risk
Cancer Res., December 15, 2005; 65(24): 11779 - 11784.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. M. Chan, P. H. Gann, and E. L. Giovannucci
Role of Diet in Prostate Cancer Development and Progression
J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. G. Nelson
Prostate Cancer Prevention
J. Nutr., November 1, 2004; 134(11): 3211S - 3212S.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
A. R. Trzeciak, S. G. Nyaga, P. Jaruga, A. Lohani, M. Dizdaroglu, and M. K. Evans
Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145
Carcinogenesis, August 1, 2004; 25(8): 1359 - 1370.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Boyiri, J. Guttenplan, M. Khmelnitsky, W. Kosinska, J.-M. Lin, D. Desai, S. Amin, B. Pittman, and K. El-Bayoumy
Mammary carcinogenesis and molecular analysis of in vivo cII gene mutations in the mammary tissue of female transgenic rats treated with the environmental pollutant 6-nitrochrysene
Carcinogenesis, April 1, 2004; 25(4): 637 - 643.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Nakayama, C. J. Bennett, J. L. Hicks, J. I. Epstein, E. A. Platz, W. G. Nelson, and A. M. De Marzo
Hypermethylation of the Human Glutathione S-Transferase-{pi} Gene (GSTP1) CpG Island Is Present in a Subset of Proliferative Inflammatory Atrophy Lesions but Not in Normal or Hyperplastic Epithelium of the Prostate: A Detailed Study Using Laser-Capture Microdissection
Am. J. Pathol., September 1, 2003; 163(3): 923 - 933.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. G. Nelson, A. M. De Marzo, and W. B. Isaacs
Prostate Cancer
N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381.
[Full Text] [PDF]


Home page
MutagenesisHome page
H. Yang, J. Holcroft, B. W. Glickman, and J. G. de Boer
Conjugated linoleic acid inhibits mutagenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the prostate of Big Blue(R) rats
Mutagenesis, March 1, 2003; 18(2): 195 - 200.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. L. Grover and F. L. Martin
The initiation of breast and prostate cancer
Carcinogenesis, July 1, 2002; 23(7): 1095 - 1102.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Yu, M. L. Jones, M. Gong, R. Sinha, H. A.J. Schut, and E. G. Snyderwine
Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high-and low-fat diets
Carcinogenesis, May 1, 2002; 23(5): 877 - 884.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
W. G. NELSON, A. M. DE MARZO, T. L. DEWEESE, X. LIN, J. D. BROOKS, M. J. PUTZI, C. P. NELSON, J. D. GROOPMAN, and T. W. KENSLER
Preneoplastic Prostate Lesions: An Opportunity for Prostate Cancer Prevention
Ann. N.Y. Acad. Sci., December 1, 2001; 952(1): 135 - 144.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. G. de Boer
Protection by Dietary Compounds against Mutation in a Transgenic Rodent
J. Nutr., November 1, 2001; 131(11): 3082S - 3086.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
G. R. Stuart, J. G. de Boer, R. Haesevoets, J. Holcroft, J. Kangas, K. Sojonky, E. Thorleifson, A. Thornton, D. F. Walsh, H. Yang, et al.
Mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats
Mutagenesis, September 1, 2001; 16(5): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Y. Burnouf, R. Miturski, M. Nagao, H. Nakagama, M. Nothisen, J. Wagner, and R. P.P. Fuchs
Early detection of 2-amino-1-methyl-6-phenylimidazo (4,5-b)pyridine(PhIP)-induced mutations within the Apc gene of rat colon
Carcinogenesis, February 1, 2001; 22(2): 329 - 335.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. P. Nelson, L. C. R. Kidd, J. Sauvageot, W. B. Isaacs, A. M. De Marzo, J. D. Groopman, W. G. Nelson, and T. W. Kensler
Protection against 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cytotoxicity and DNA Adduct Formation in Human Prostate by Glutathione S-Transferase P1
Cancer Res., January 1, 2001; 61(1): 103 - 109.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.